Legal & General Group PLC Arvinas, Inc. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 53,610 shares of ARVN stock, worth $981,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,610
Previous 62,954
14.84%
Holding current value
$981,599
Previous $1.55 Million
33.74%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ARVN
# of Institutions
228Shares Held
72.8MCall Options Held
719KPut Options Held
290K-
Vanguard Group Inc Valley Forge, PA7.06MShares$129 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$123 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$115 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$75.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$61.1 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $974M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...